MCP
MDCO

Moab Capital Partners’s Medicines Co MDCO Stock Holding History

Moab Capital Partners’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-521,987
Closed -$44.3M – 32
2019
Q4 		$44.3M Buy
+521,987
New +$34.8M 17.51% 2

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Moab Capital Partners's MDCO Position: Q1 2020 in Review

Moab Capital Partners sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 521,987 shares — an estimated $44.3M sold.

Moab Capital Partners first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $44.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Moab Capital Partners reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Moab Capital Partners sold 521,987 Medicines Co shares in Q1 2020, an estimated $44.3M.
  • Moab Capital Partners first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
  • Moab Capital Partners's Medicines Co position peaked at $44.3M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Moab Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.